If kratom use is hard to control, is causing harm, or stopping brings withdrawal symptoms, ask a qualified clinician for an assessment. Kratom can lead to dependence and withdrawal, but evidence for treating kratom use disorder (KUD) is limited; the right next step is an individualized plan, not a do-it-yourself detox or medication protocol.
You do not need to decide in advance whether your use qualifies as an addiction, or wait until you are ready to stop completely, before asking for help. A clinician can discuss what is happening, consider whether other health or substance-use concerns are involved, and explain what kinds of support may be appropriate. This guide summarizes what the available evidence can—and cannot—say; it is not a self-treatment manual.
When to seek an assessment
Kratom itself may be addictive, and people who use it regularly may experience withdrawal when they stop, according to the National Center for Complementary and Integrative Health (NCCIH). It is reasonable to seek help if you find it difficult to reduce or stop, use more than you intend, experience withdrawal, or notice consequences in your health or daily life. You do not have to wait for a crisis or prove that your use meets a particular label before asking for help.
“Kratom addiction” is a common way to describe concern about use, while clinicians may use the term kratom use disorder. The 2024 clinical review by Kirsten E. Smith, David H. Epstein, and Stephanie T. Weiss recommends a systematic assessment using DSM-5 substance-use-disorder criteria. This approach looks at the pattern and consequences of use, rather than treating frequency alone or one symptom as a diagnosis.
Free tools Windows power users keep installed
One-click scans. No signup required.
#1 Best Overall
- HD streaming made simple: With America’s number 1 TV streaming platform,* exploring popular apps—plus tons of free movies, shows, and live TV—is as easy as it is fun. *Based on hours streamed—Hypothesis Group
- Compact without compromises: The sleek design of Roku Streaming Stick won’t block neighboring HDMI ports, and it even powers from your TV alone, plugging into the back and staying out of sight. No wall outlet, no extra cords, no clutter.
- No more juggling remotes: Power up your TV, adjust the volume, and control your Roku device with one remote. Use your voice to quickly search, play entertainment, and more.
- Shows on the go: Take your TV to-go when traveling—without needing to log into someone else’s device.
- TV, simplified: With setup that only takes minutes, a simple-to-navigate Home Screen, and an uncluttered remote control that does all you need—Roku makes it easier to watch the TV you love.
Tolerance, withdrawal, craving, and taking more than intended appear among the criteria described in published reports. However, the 2024 review notes that reports often do not document a complete DSM-5 assessment. That gap is one reason not to diagnose yourself from an online checklist or assume that someone else’s experience predicts yours. A qualified clinician can ask about the full pattern, assess whether use is causing problems, and consider other explanations or co-occurring conditions.
The assessment should also consider whether opioid use disorder (OUD), another substance-use disorder, or other health conditions are present. This matters because treatment decisions can differ when KUD occurs alongside OUD. Tell the clinician about other substances and medications as well as kratom; the purpose is to help them understand the whole situation, not to pass a test or earn a particular label.
How to get started
- Choose a point of entry. Contact a primary-care clinician, an addiction-medicine clinician, or a behavioral-health service that assesses substance use. Ask whether they have experience with kratom, withdrawal, and co-occurring OUD. If you already have a clinician, ask for an assessment or referral. If the first service cannot assess kratom use, ask where it can direct you and verify the next service’s capabilities before relying on the referral.
- Prepare a clear account of use. Be ready to describe the product, including extracts or 7-hydroxymitragynine (7-OH) products if relevant; the amount and frequency; how long you have used it; when you last used it; any symptoms when reducing or stopping; other substances or medications; and prior attempts to cut down. If you have product packaging or can identify its name, that may help you explain what you used. This information helps inform a clinical conversation; it is not a validated KUD scoring tool, and you do not need to calculate a dose or classify your use before seeking care.
- Disclose use directly. A routine urine drug screen may not detect kratom, according to a 2021 primary-care review. Tell the clinician what you have taken and, if possible, identify the product. Do not assume a negative routine screen rules out kratom use, or wait for a test result before raising the issue. Direct disclosure gives the clinician context that a routine screen may not supply.
- Ask about the assessment and plan. Ask what the assessment found, whether withdrawal care or longer-term treatment is being considered, what each option is intended to address, and how follow-up will work. You can ask whether the clinician considered KUD criteria, possible OUD, and other needs; whether a medication is being considered for a specific clinical reason; and who will monitor it. If you are referred elsewhere, verify that the program can assess kratom use and any co-occurring needs.
- Use local emergency services for emergencies. If symptoms are severe or rapidly worsening, there is an acute medical emergency, or someone is in immediate danger, contact local emergency services. The reviewed sources do not establish a kratom-specific emergency triage checklist or symptom threshold, so this article cannot provide a safe substitute for urgent assessment.
Referral options vary by location. The sources reviewed do not verify a particular current local provider or a national kratom-specific referral pathway. Ask a clinician for a geographically appropriate referral or use a reputable treatment locator, then confirm directly that the service can assess kratom use and address co-occurring needs. NCCIH’s information service provides health information, not treatment referrals; do not treat its Clearinghouse as a provider directory.
When contacting a service, it is reasonable to ask whether it offers an initial clinical assessment, what type of withdrawal or ongoing care it can provide, and whether it coordinates referrals when a different level of care is needed. No specific provider, geographic coverage, or referral service has been verified for this guide. Availability and the appropriate pathway depend on where you live and your clinical needs.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →What treatment can and cannot be said to work
There is no strong comparative evidence that identifies one proven treatment for isolated KUD or ranks treatment settings. The literature includes clinical reports and expert-practice information, not a settled treatment protocol. A 2021 systematic literature review by Stanciu and colleagues identified 14 reports of long-term KUD management. Most described buprenorphine; fewer described methadone or naltrexone. Fourteen is the count of reports discussed by that review, not a count of controlled trials. These reports cannot establish that a medication is safe and effective for everyone with KUD, or show that one approach works better than another.
The 2024 review likewise states that no controlled studies establish buprenorphine’s safety or efficacy for isolated KUD. That does not mean a clinician can never consider medication; it means the evidence base does not support presenting a particular medicine or dose as a proven universal answer. Medication decisions for isolated KUD remain controversial and require individual clinical judgment. Do not copy a dose or treatment schedule from a case report, and do not start, stop, or change a medication on the basis of another person’s experience.
Rank #2
- Ultra-speedy streaming: Roku Ultra is 30% faster than any other Roku player, delivering a lightning-fast interface and apps that launch in a snap.
- Cinematic streaming: This TV streaming device brings the movie theater to your living room with spectacular 4K, HDR10+, and Dolby Vision picture alongside immersive Dolby Atmos audio.
- The ultimate Roku remote: The rechargeable Roku Voice Remote Pro offers backlit buttons, hands-free voice controls, and a lost remote finder.
- No more fumbling in the dark: See what you’re pressing with backlit buttons.
- Say goodbye to batteries: Keep your remote powered for months on a single charge.
| Care or treatment discussed | What the evidence supports | Practical implication |
|---|---|---|
| Buprenorphine | Reported in most of the 14 long-term management reports identified by Stanciu et al. in 2021. The 2024 review says controlled studies have not established its safety or efficacy for isolated KUD. | A qualified prescriber may consider it for an individualized clinical reason. Ask what concern it is intended to address and how it would be monitored. Do not treat case-report dosing as a self-treatment plan. |
| Methadone or naltrexone | Described in fewer reports in the 2021 review; the available reports do not establish comparative effectiveness for isolated KUD. | Any medication decision belongs in a clinician’s assessment of the person’s circumstances and co-occurring conditions. The fact that a medicine appears in a report is not proof that it is appropriate for a particular person. |
| Medication for co-occurring OUD | The 2024 review discusses medication for OUD as the first-line approach when KUD co-occurs with OUD and treatment is clinically appropriate. | Ask the clinician to assess OUD rather than treating kratom use in isolation. If OUD is present, the treatment discussion may be different from a plan for isolated KUD. |
| Cognitive behavioral therapy or acceptance and commitment therapy | The 2024 review describes these as possible behavioral-care adjuncts; direct evidence specifically for KUD remains sparse. | They may be considered if wanted, as part of a broader plan. For co-occurring OUD, the review cautions against relying on non-medication therapy alone. |
| Medically managed withdrawal or residential care | Care setting depends on clinical need. A 2025 report describes one inpatient withdrawal case involving daily 7-OH use, symptom-based buprenorphine, and transition to residential care; one case does not establish a standard pathway. | Discuss the appropriate setting and continuity of care with a clinician; residential treatment is not established as necessary for everyone. |
Behavioral support and medication are not interchangeable evidence claims. The review says cognitive behavioral therapy or acceptance and commitment therapy may be considered as adjuncts when a patient wants them, but evidence specifically for KUD is sparse. A clinician can discuss whether behavioral-health support fits your preferences and broader needs. In particular, when OUD is also present, the review cautions against relying on non-medication therapies alone.
It is useful to distinguish withdrawal management from longer-term treatment. Care that addresses a period of withdrawal does not, by itself, establish what ongoing support will be needed or how follow-up will happen. Ask what the next step is after withdrawal care, if that is part of your plan, and whether the service will coordinate a transition. A 2025 report describes one inpatient case involving daily 7-OH use, symptom-based buprenorphine, and transition to residential care. It is an example of one person’s care, not evidence that everyone needs inpatient or residential treatment, or that the same sequence is appropriate for others.
The reviewed research does not provide a universal medication protocol, consumer detox manual, or comparative success rates for KUD treatment. Nor does it establish that outpatient, medically managed withdrawal, or residential care is best for all patients. A clinician should explain how the proposed setting relates to the assessment and the person’s circumstances, rather than treating a case report as a rule.
How to compare care options
Because the evidence does not establish a best medication or setting for every person, compare programs by what they assess and how they plan care. Useful questions include:
- Does the assessment address KUD criteria, withdrawal, and possible OUD or other conditions, rather than focusing only on frequency of use?
- Can the service explain why outpatient care, medically managed withdrawal, or residential care is being considered in this specific case? Is that recommendation based on an assessment rather than a promise or a one-size-fits-all pathway?
- If medication is proposed, what clinical issue is it intended to address, who will prescribe and monitor it, and how will progress be reviewed? Is the recommendation for co-occurring OUD or for isolated KUD, where the evidence is more limited?
- Is behavioral-health support available, and can the plan reflect the patient’s preferences? If it is offered, is it described as an adjunct rather than as a proven stand-alone treatment for KUD?
- What follow-up or continuity of care is available after withdrawal management? Who will help coordinate the next service if the program itself does not provide longer-term care?
- Can the program explain its limits honestly, including when it cannot provide the assessment or type of care needed, and help identify an appropriate referral?
A program’s ability to discuss these questions is more informative than a promise of a guaranteed result. The available literature does not support ranking KUD treatments by success rate. It also does not verify a particular treatment locator or provider for every region, so confirm a service’s location, clinical capabilities, and referral arrangements directly.
There is no evidence-based price comparison in the sources reviewed, and costs will depend on the provider, location, and care setting. If cost or insurance affects your choices, ask the provider directly what an assessment and proposed services would cost, what payment or coverage options may apply, and whether a referral is available. These practical questions do not indicate which treatment is clinically best; they can help you understand whether a particular service is accessible to you.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minutePC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Rank #3
- 4K streaming made simple:With America’s number 1 TV streaming platform,* exploring popular apps—plus tons of free movies, shows, and live TV—is as easy as it is fun. *Based on hours streamed—Hypothesis Group
- 4K picture quality: With Roku Streaming Stick Plus, watch your favorites with brilliant 4K picture and vivid HDR color.
- Compact without compromises: Our sleek design won’t block neighboring HDMI ports, and it even powers from your TV alone, plugging into the back and staying out of sight. No wall outlet, no extra cords, no clutter.
- No more juggling remotes: Power up your TV, adjust the volume, and control your Roku device with one remote. Use your voice to quickly search, play entertainment, and more.
- Shows on the go: Take your TV to-go when traveling—without needing to log into someone else’s device.
Why kratom is not an established treatment
Some people use kratom in attempts to manage opioid withdrawal, but NCCIH states: “However, kratom has not been shown to be safe and effective for this or any other medical use.” NCCIH also notes possible dependence and withdrawal, side effects, uncertain interactions, and contamination concerns. Using kratom to treat kratom-related problems is therefore not an evidence-based substitute for clinical assessment. The potential for dependence and uncertainty about interactions are additional reasons to tell a clinician what product you have used rather than adding or substituting products on your own.
On June 1, 2026, the National Institutes of Health announced that an investigational new drug application for purified mitragynine had taken effect, enabling a planned first human safety and tolerability study. NIH said, “The compound in isolation has yet to be studied in humans.” This announcement concerns early-stage research into a potential OUD treatment. An investigational study is not an established treatment, does not mean the compound is available as routine care, and does not demonstrate treatment effectiveness for KUD.
Frequently asked questions
Can kratom be addictive?
Yes. NCCIH says kratom itself may be addictive and that regular users may experience withdrawal when they stop. Difficulty controlling use, harm, or withdrawal are reasonable reasons to ask a clinician for an assessment. These concerns do not require you to diagnose yourself before seeking care.
How do I get help for kratom withdrawal?
Contact a primary-care or addiction-medicine clinician, or a behavioral-health service that assesses substance use. Explain what product you used, when you last used it, your symptoms, and any other substances or medications. A clinician can assess what kind of care is appropriate; do not rely on a self-directed detox protocol. If symptoms are severe or rapidly worsening, there is an acute medical emergency, or someone is in immediate danger, contact local emergency services.
Will a drug test show kratom?
A routine urine drug screen may not detect kratom. Tell the clinician directly about your use and the product, rather than relying on a screening result to communicate it. A negative routine screen does not rule out kratom use.
What treatment works for kratom addiction?
No controlled evidence establishes a universally effective medication for isolated KUD. Published reports describe buprenorphine and, less often, methadone or naltrexone; behavioral approaches may be considered as adjuncts, but direct evidence for KUD is sparse. A clinician should assess the person’s needs, including possible co-occurring OUD, before recommending a plan.
Rank #4
- Stunning 4K and Dolby Vision streaming made simple: With America’s number 1 TV streaming platform,* exploring popular apps—plus tons of free movies, shows, and live TV—is as easy as it is fun. *Based on hours streamed—Hypothesis Group
- Breathtaking picture quality: Stunningly sharp 4K picture brings out rich detail in your entertainment with four times the resolution of HD. Watch as colors pop off your screen and enjoy lifelike clarity with Dolby Vision and HDR10+.
- Seamless streaming for any room: With Roku Streaming Stick 4K, watch your favorite entertainment on any TV in the house, even in rooms farther from your router thanks to the long-range Wi-Fi receiver.
- Shows on the go: Take your TV to-go when traveling—without needing to log into someone else’s device.
- Compact without compromises: Our sleek design won’t block neighboring HDMI ports, so you can switch from streaming to gaming with ease. Plus, it’s designed to stay hidden behind your TV, keeping wires neatly out of sight
Is buprenorphine a proven treatment for isolated KUD?
No controlled studies establish its safety or efficacy for isolated KUD, according to the 2024 review. It appears in published management reports, but that is not the same as controlled proof. A qualified clinician can consider whether medication has a specific role in an individual case; case-report dosing should not be used as a personal protocol.
Should I use kratom to treat withdrawal or dependence?
No. NCCIH says kratom has not been shown safe and effective for any medical use, and notes possible dependence, withdrawal, side effects, interaction uncertainties, and contamination concerns. Seek a clinical assessment instead of using kratom as a treatment for kratom-related problems or opioid withdrawal.
Does everyone need residential treatment?
No. The available evidence does not establish residential care as necessary for everyone. The 2025 report describes one inpatient withdrawal case followed by residential care, not a standard pathway. Ask a clinician to explain the setting recommended for your circumstances and how care and follow-up would continue.
Does the NIH mitragynine announcement mean a new treatment is available?
No. The June 1, 2026 announcement said an investigational new drug application for purified mitragynine had taken effect, enabling a planned first human safety and tolerability study. NIH also said the isolated compound had yet to be studied in humans. This is early-stage research, not an established or available treatment for KUD.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Frequently Asked Questions
Can kratom be addictive?
Yes. NCCIH says kratom itself may be addictive and regular users may experience withdrawal when they stop. Difficulty controlling use, harm, or withdrawal are reasonable reasons to ask a clinician for an assessment.
How do I get help for kratom withdrawal?
Contact a primary-care or addiction-medicine clinician, or a behavioral-health service that assesses substance use. Share the product, last use, symptoms, and other substances or medications. A clinician can assess appropriate care; seek local emergency services for an acute emergency or immediate danger.
Recommended Free Tools
Best Value
- The Google TV Streamer (4K) delivers your favorite entertainment quickly, easily, and personalized to you[1,2]
- HDMI 2.1 cable required (sold separately)
- See movies and TV shows from all your services right from your home screen[2]; and find new things to watch with tailored recommendations for everyone in your home based on their interests and viewing habits
- Watch live TV and access over 800 free channels from Pluto TV, Tubi, and more[3]; if you find an interesting show or movie on your TV, mobile app, or Google search, you can easily add it to your watchlist, so it’s ready when you are[2]
- Up to 4K HDR with Dolby Vision delivers captivating, true-to-life detail[4]; and you can connect speakers that support Dolby Atmos for more immersive 3D sound
Will a drug test show kratom?
A routine urine drug screen may not detect kratom. Tell the clinician directly what you used; a negative routine screen does not rule out kratom use.
What treatment works for kratom addiction?
No controlled evidence establishes a universally effective medication for isolated KUD. Published reports describe medications and behavioral approaches, but evidence is limited. A clinician should assess individual needs, including possible co-occurring OUD.
Is buprenorphine a proven treatment for isolated KUD?
No controlled studies establish its safety or efficacy for isolated KUD. It appears in published reports, but that is not controlled proof; medication decisions belong with a qualified clinician.
Should I use kratom to treat withdrawal or dependence?
No. NCCIH says kratom has not been shown safe and effective for medical use and notes possible dependence, withdrawal, side effects, interaction uncertainties, and contamination concerns. Seek a clinical assessment instead.
Does everyone need residential treatment?
No. The evidence does not establish residential care as necessary for everyone. A 2025 report describes one case, not a standard pathway. Ask a clinician what setting fits the individual assessment.
Does the NIH mitragynine announcement mean a new treatment is available?
No. The June 1, 2026 announcement described a planned first human safety and tolerability study of purified mitragynine. This is early-stage research, not established or available treatment for KUD.
The Bottom Line
If kratom use is difficult to control, causes harm, or brings withdrawal when you stop, start with a qualified clinician’s assessment. Be direct about the product and your pattern of use, and ask whether the assessment considers withdrawal, possible OUD, and other needs. Treatment reports offer possible avenues for discussion, not a proven universal KUD protocol; medication, care setting, and follow-up should be individualized. Kratom itself is not an established medical treatment.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
